RAJ NARAYAN: Open Payments
NPI 1699978163 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$958 in 69 payments from 10 companies in 2025. Trend: 2023 $823 · 2024 $657 · 2025 $958
Food & beverage: $931Education: $27
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 49 | $492 |
| Teva Pharmaceuticals USA, Inc. | 7 | $213 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| E.R. Squibb & Sons, L.L.C. | 2 | $48 |
| Collegium Pharmaceutical, Inc. | 2 | $33 |
| Alkermes, Inc. | 2 | $32 |
| Janssen Pharmaceuticals, Inc | 2 | $31 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
Products named: VRAYLAR, UZEDY, CAPLYTA, COBENFY, AUSTEDO XR, Jornay PM, ARISTADA, INVEGA SUSTENNA.
Industry payments across PA — which companies pay providers there.
